Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trials
Cancer research team finds promising new use for discarded anti-cancer drug
August 4th, 2005
H. Lee Moffitt Cancer Center & Research Institute, working in partnership with the University of South Florida (U.S.F), has discovered a new use for an old, previously discredited anti-cancer drug that could be another weapon against several cancers, including tumors of the breast, ovary, colon, skin and prostate. The compound, tricirbine, was tested at various cancer centers until 1996 and found to inhibit some cancers, but researchers failed to determine the reasons. The Moffitt-U.S.F team discovered that tricirbine works only against tumors in which the cancer-causing Akt protein is abundant or abnormally active. "These tumors are addicted to...
Source: Women's Health Weekly (2005-08-04)
|
